Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Sessions onDemand |
03/11/2025 to 03/10/2027 |
$149.00 |
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
03/11/2025 to 03/10/2027 |
$149.00 |
Gray Zone - Unresectable Pancreatic Adenocarcinoma: Evidence-Based Medicine or a Gut Feeling? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
03/13/2025 to 03/12/2026 |
$0.00 |
ASTRO ROCKS: Promotion and Tenure |
- 1.00 Certificate of Attendance
|
Webinars |
03/14/2025 to 04/10/2027 |
$0.00 |
Implementation of a Prostate SBRT Program in the Community Setting |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
03/18/2025 to 03/17/2027 |
$149.00 |
Science Highlights 2024: Breast Cancer |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Certificate of Attendance
|
Sessions onDemand |
03/24/2025 to 12/31/2025 |
$79.00 |
The Hidden Risks of Artificial Intelligence (AI): Biases and Disparities in the Global Development and Deployment of AI for Cancer Care |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
03/25/2025 to 03/24/2027 |
$149.00 |
Moving Beyond Auditory Speech: Improving Equity for Patients and Providers with Diverse Communication Needs |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
03/25/2025 to 03/24/2027 |
$0.00 |
Appropriateness Criteria for Radiotherapy in the Setting of Presumed Early-stage Lung Cancer |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
03/26/2025 to 03/25/2027 |
$49.00 |
2025 Quarter 2 - Journal Reviewer CME |
- 3.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/01/2025 to 07/31/2025 |
$0.00 |
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations |
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Certificate of Attendance
|
Sessions onDemand |
04/01/2025 to 03/31/2027 |
$149.00 |
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Sessions onDemand |
04/08/2025 to 04/07/2027 |
$149.00 |
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/14/2025 to 04/13/2026 |
$0.00 |
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC... |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/14/2025 to 04/13/2027 |
$49.00 |
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time? |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
04/15/2025 to 04/14/2027 |
$149.00 |